Skip to content

Research at St Andrews

Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction

Research output: Contribution to journalArticlepeer-review

DOI

Author(s)

Rona Ruth Ramsay, C Dunford, P.K. Gillman

School/Research organisations

Abstract

Background and purpose: Monoamine oxidase inhibitors (MAOI) are known to cause serotonin toxicity (ST) when administered with selective serotonin reuptake inhibitors (SSRI). Methylene blue (methylthionium chloride, MB), a redox dye in clinical use, has been reported to precipitate ST in patients using SSRI. MB was assessed for MAO inhibition and so for its potential to precipitate ST.

Experimental approach: Inhibition of purified human MAO was quantified using kinetic assays and visible spectral changes to study the interactions of MB with MAO A.

Key results: MB was a potent (tight binding) inhibitor for MAO A. It also inhibited MAO B but at much higher concentration. Interactions of MB with the active site of MAO A were confirmed by its action both as an oxidising substrate and as a one-electron reductant.

Conclusions and implications: MB is a potent reversible inhibitor of MAO A with implications for gut uptake of amines when administered orally. At concentrations reported in the literature after intravenous administration, MAO B would be partially inhibited but MAO A would be completely inhibited. This inhibition of MAO A would be expected to lead to perturbations of 5-hydroxytryptamine metabolism and hence account for ST occurring when administered to patients on SSRI treatment.

Close

Details

Original languageEnglish
Pages (from-to)946-951
Number of pages6
JournalBritish Journal of Pharmacology
Volume152
Issue number6
DOIs
Publication statusPublished - Nov 2007

    Research areas

  • methylene blue, methylthionium chloride, serotonin toxicity, monoamine oxidase A, MAOI, tight binding, IFOSFAMIDE ENCEPHALOPATHY, REVERSIBLE INHIBITION, MECHANISM, OXIDATION, FLUORESCENCE, KINETICS, ANALOGS, MONOMER, BINDING

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Parameters for irreversible inactivation of monoamine oxidase

    Ramsay, R. R., Basile, L., Maniquet, A., Hagenow, S., Pappalardo, M., Saija, M. C., Bryant, S., Albreht, A. & Guccione, S., 13 Dec 2020, In: Molecules. 25, 24, 25 p., 5908.

    Research output: Contribution to journalArticlepeer-review

  2. Neuroprotective actions of leptin facilitated through balancing mitochondrial morphology and improving mitochondrial function

    Cheng, Y., Buchan, M., Vitanova, K., Aitken, L., Gunn-Moore, F. J., Ramsay, R. R. & Doherty, G., 13 Oct 2020, In: Journal of Neurochemistry. 155, 2, p. 191-206 e15003.

    Research output: Contribution to journalArticlepeer-review

  3. Design, synthesis, molecular modelling and in vitro screening of monoamine oxidase inhibitory activities of novel quinazolyl hydrazine derivatives

    Amer, A., Hegazi, A. H., Alshekh, M. K., Ahmed, H. E. A., Soliman, S. M., Maniquet, A. & Ramsay, R. R., 22 Apr 2020, In: Royal Society Open Science. 7, 18 p., 200050.

    Research output: Contribution to journalArticlepeer-review

  4. Synthesis, biological evaluation, and molecular modeling of nitrile-containing compounds: exploring multiple activities as anti-Alzheimer agents

    Silva, D., Mendes, E., Summers, E. J., Neca, A., Jacinto, A. C., Reis, T., Agostinho, P., Bolea, I., Jimeno, M. L., Mateus, M. L., Oliveira-Campos, A. M. F., Unzeta, M., Marco-Contelles, J., Majekova, M., Ramsay, R. R. & Carreiras, M. C., 30 Aug 2019, In: Drug Development Research. Early View, DDR-19-0121.R1.

    Research output: Contribution to journalArticlepeer-review

  5. Electron carriers and energy conservation in mitochondrial respiration

    Ramsay, R. R., Jun 2019, In: ChemTexts. 5, 14 p., 9.

    Research output: Contribution to journalArticlepeer-review

Related by journal

  1. Trichostatin A blocks aldosterone-induced Na+ transport and control of serum- and glucocorticoid-inducible kinase 1 in cortical collecting duct cells

    Mansley, M. K., Roe, A. J., Francis, S. L., Gill, J. H., Bailey, M. A. & Wilson, S. M., 16 Jan 2020, In: British Journal of Pharmacology. 176, 24, p. 4708-4719 12 p.

    Research output: Contribution to journalArticlepeer-review

  2. Updating neuropathology and neuropharmacology of monoaminergic systems

    Ramsay, R. R., De Deurwaerdère, P. & Di Giovanni, G., Jul 2016, In: British Journal of Pharmacology. 173, 13, p. 2065-2068 4 p.

    Research output: Contribution to journalEditorial

  3. GABAB receptor subtypes differentially modulate synaptic inhibition in the dentate gyrus to enhance granule cell output

    Foster, J. D., Kitchen, I., Bettler, B. & Chen, Y., 1 Apr 2013, In: British Journal of Pharmacology. 168, 8, p. 1808-1819

    Research output: Contribution to journalArticlepeer-review

  4. Dysregulation of epithelial Na + absorption induced by inhibition of the kinases TORC1 and TORC2

    Mansley, M. K. & Wilson, S. M., 1 Dec 2010, In: British Journal of Pharmacology. 161, 8, p. 1778-1792 15 p.

    Research output: Contribution to journalArticlepeer-review

  5. Effects of nominally selective inhibitors of the kinases PI3K, SGK1 and PKB on the insulin-dependent control of epithelial Na + absorption

    Mansley, M. K. & Wilson, S. M., 1 Oct 2010, In: British Journal of Pharmacology. 161, 3, p. 571-588 18 p.

    Research output: Contribution to journalArticlepeer-review

ID: 379328

Top